PMID- 16880407 OWN - NLM STAT- MEDLINE DCOM- 20061025 LR - 20231213 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 103 IP - 31 DP - 2006 Aug 1 TI - Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. PG - 11736-41 AB - We have demonstrated that cytokine thymic stromal lymphopoietin (TSLP), whose expression is rapidly induced upon keratinocyte-selective ablation of retinoid X receptors (RXRs) -alpha and -beta in the mouse (RXRalphabeta(ep-/-) mice), plays a key role in initiating a skin and systemic atopic dermatitis-like phenotype. We show here that topical application of the physiologically active ligand [1alpha,25-(OH)(2)D(3); calcitriol] of the vitamin D receptor, or of its low-calcemic analog MC903 (calcipotriol; Dovonex), induces TSLP expression in epidermal keratinocytes, which results in an atopic dermatitis-like syndrome mimicking that seen in RXRalphabeta(ep-/-) mutants and transgenic mice overexpressing TSLP in keratinocytes. Furthermore, topical application of retinoic acid receptor RARgamma-selective agonist BMS961 also induces TSLP expression either on its own or synergistically with 1alpha,25-(OH)(2)D(3). Our data demonstrate that RXR/vitamin D receptor and RXR/retinoic acid receptor-gamma heterodimers and their ligands cell-autonomously control the expression of TSLP in epidermal keratinocytes of the mouse. We propose molecular mechanisms through which vitamin D3 and retinoic acid signalings could be involved in the pathogenesis of atopic diseases. FAU - Li, Mei AU - Li M AD - Institut de Genetique et de Biologie Moleculaire et Cellulaire and Institut Clinique de la Souris, BP10142, 67404 Illkirch Cedex, France. FAU - Hener, Pierre AU - Hener P FAU - Zhang, Zhikun AU - Zhang Z FAU - Kato, Shigeaki AU - Kato S FAU - Metzger, Daniel AU - Metzger D FAU - Chambon, Pierre AU - Chambon P LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060731 PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (BMS 961) RN - 0 (Cytokines) RN - 0 (Dermatologic Agents) RN - 0 (Receptors, Calcitriol) RN - 0 (Receptors, Retinoic Acid) RN - 0 (Retinoid X Receptor alpha) RN - 0 (Retinoid X Receptor beta) RN - 0 (Retinoids) RN - 0 (Vitamins) RN - 143NQ3779B (calcipotriene) RN - FXC9231JVH (Calcitriol) RN - SY7Q814VUP (Calcium) RN - GT0IL38SP4 (Thymic Stromal Lymphopoietin) SB - IM MH - Administration, Topical MH - Animals MH - Calcitriol/administration & dosage/adverse effects/*analogs & derivatives/immunology MH - Calcium/metabolism MH - Cells, Cultured MH - Cytokines/genetics/*immunology MH - *Dermatitis, Atopic/chemically induced/immunology MH - *Dermatologic Agents/administration & dosage/adverse effects/immunology MH - Dimerization MH - Female MH - Humans MH - Keratinocytes/cytology/*immunology MH - Mice MH - Mice, Knockout MH - Mice, Transgenic MH - Receptors, Calcitriol/genetics/metabolism MH - Receptors, Retinoic Acid/agonists/genetics/metabolism MH - Retinoid X Receptor alpha/agonists/genetics/metabolism MH - Retinoid X Receptor beta/agonists/genetics/metabolism MH - Retinoids/immunology MH - Skin/cytology/drug effects/pathology MH - *Vitamins/administration & dosage/adverse effects/chemistry/immunology MH - Thymic Stromal Lymphopoietin MH - Retinoic Acid Receptor gamma PMC - PMC1544239 COIS- Conflict of interest statement: No conflicts declared. EDAT- 2006/08/02 09:00 MHDA- 2006/10/26 09:00 PMCR- 2007/02/01 CRDT- 2006/08/02 09:00 PHST- 2006/08/02 09:00 [pubmed] PHST- 2006/10/26 09:00 [medline] PHST- 2006/08/02 09:00 [entrez] PHST- 2007/02/01 00:00 [pmc-release] AID - 0604575103 [pii] AID - 2873 [pii] AID - 10.1073/pnas.0604575103 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11736-41. doi: 10.1073/pnas.0604575103. Epub 2006 Jul 31.